Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy

被引：2

作者：

Yalta, Kenan ^{[1
]}

Yetkin, Erta ^{[1
]}

机构：

[1] Trakya Univ, Sch Med, Cardiol Dept, Edirne, Turkey

来源：

CJC OPEN | 2022年 / 4卷 / 09期

关键词：

D O I：

10.1016/j.cjco.2022.07.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：823 / 824

页数：2

共 4 条

[1] HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis [J].

Birnie, David H. ;

Sauer, William H. ;

Bogun, Frank ;

Cooper, Joshua M. ;

Culver, Daniel A. ;

Duvernoy, Claire S. ;

Judson, Marc A. ;

Kron, Jordana ;

Mehta, Davendra ;

Nielsen, Jens Cosedis ;

Patel, Amit R. ;

Ohe, Tohru ;

Raatikainen, Pekka ;

Soejima, Kyoko .

HEART RHYTHM, 2014, 11 (07) :1304-1323

[2]

Powell RGG, 2021, CJC OPEN, V4, P432

[3] Risks and Challenges of Implantable Cardioverter-Defibrillators in Young Adults [J].

Sherrid, Mark V. ;

Daubert, James P. .

PROGRESS IN CARDIOVASCULAR DISEASES, 2008, 51 (03) :237-263

[4] Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis [J].

Yoshitomi, Ryosuke ;

Kobayashi, Shigeki ;

Yano, Yasutake ;

Nakashima, Yusuke ;

Fujii, Shohei ;

Nanno, Takuma ;

Ishiguchi, Hironori ;

Fukuda, Masakazu ;

Yoshiga, Yasuhiro ;

Okamura, Takayuki ;

Suga, Kazuyoshi ;

Kawano, Reo ;

Yano, Masafumi .

HEART, 2022, 108 (06) :429-437

← 1 →